Faster onset predicts higher purchase intent. Here's the data.

The formulation variable that predicts whether someone buys again — and it doesn't increase negative effects.

Part of the Functional Beverage Study series — findings from Cohort 1, a real-world, longitudinal study of 2,580 consumers across 20 products.

Onset speed isn't just a product-experience metric. It's a predictor of commercial outcomes — purchase intent, recommendation, and the likelihood of a positive experience. We modeled all three across the full cohort. The results were statistically significant in every case. And there's no negative tradeoff.

The punchline

Across the full cohort, faster onset was a statistically significant predictor of higher purchase intent, stronger recommendation, and a dramatically higher likelihood of positive effects — all without increasing negative effects.

The onset landscape

64% of participants felt effects within 40 minutes, with the most common window being 21–40 minutes (29.1%). But onset varied widely: 13.1% reported feeling no effects at all, while 5.7% felt them within 5 minutes.

That variation matters, because onset speed isn't just a product-experience metric — it's a predictor of commercial outcomes.

Faster onset predicts higher purchase intent We modeled the relationship between onset speed and purchase intent across the full cohort. The result was statistically significant (p <.05).

Participants who felt no effects had the lowest purchase intent. Participants who felt effects quickly scored significantly higher. The sooner someone feels the product working, the more likely they are to buy it again.

Faster onset predicts stronger recommendation

Same pattern, same statistical significance.

We asked participants at the end of the study whether they'd recommend the product to others (1 = strongly disagree, 5 = strongly agree). Participants who felt no effects landed around neutral. Participants who felt effects quickly landed between "agree" and "strongly agree."

Faster onset dramatically increases positive effects

This was the starkest finding. The faster the onset, the higher the likelihood of a positive experience and the stronger the positive effect ratings. This wasn't a marginal difference. The gap between "felt no effects" and "felt effects" was an order of magnitude.

And onset does NOT increase negative effects

Faster onset did not produce a statistically significant increase in the probability of reporting a negative effect. The relationship between onset speed and negative experiences was flat — no signal.

Faster onset was actually associated with a meaningful reduction in how intense those negative effects were.

In this dataset, there is no evidence that faster onset carries a downside trade-off. The upside is statistically significant. The downside is not.

What this suggests

1. Onset speed is a competitive differentiator hiding in plain sight. Most functional beverage brands market on flavor, dose, or occasion. The data says that how quickly the product kicks in may matter more to repeat purchase and recommendation than any of those — and almost nobody is leading with it.

2. The fast-onset technology market just got a business case. Brands evaluating fast-onset formulation technologies (nano-emulsion, liposomal delivery, water-soluble actives) have historically justified the investment on product quality alone. This data connects that investment directly to purchase intent and recommendation — the two metrics that drive revenue.

3. "Felt no effects" is the real competitor. 13.1% of product-use-day responses reported feeling no effects. That group had the lowest purchase intent, the lowest recommendation scores, and the lowest probability of reporting a positive experience on any given day. For the category, the biggest threat to repeat purchase isn't a competing brand — it's a consumer who drinks your product and feels nothing.

4. This changes how you evaluate product-market fit. If your product has a fast-onset profile, that's a measurable commercial advantage. If it doesn't, the data quantifies what you're leaving on the table. Onset belongs in the same conversation as taste, price, and packaging — it's a revenue variable, not just a formulation spec.

Method note: Self-reported, real-world observational dataset (Cohort 1; N=2,580; 20 beverages).